NCT07320534 2026-01-08
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Gadjah Mada University
Phase 4 Not yet recruiting
Clinical Trials
16 trialsNCT04948463 2025-12-24
ELSA-FN
Murdoch Childrens Research Institute
Phase 4 Completed
NCT07016165 2025-08-22
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Gadjah Mada University
Phase 4 Recruiting
NCT06665737 2025-01-28
G-CSF in NHL
Department of Medical Services Ministry of Public Health of Thailand
Phase 4 Not yet recruiting
NCT06616571 2024-09-27
Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
Qilu Pharmaceutical Co., Ltd.
Phase 4 Recruiting
NCT05784844 2024-09-19
Antimicrobial Revision in Persistent Febrile Neutropenia
Wake Forest University Health Sciences
Phase 4 Withdrawn
NCT06293677 2024-07-11
DAR-ARC
Centre Hospitalier Universitaire Vaudois
Phase 4 Recruiting
NCT05061654 2023-08-14
CEF-10
Hamad Medical Corporation
Phase 4 Withdrawn
NCT05393505 2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4 Unknown
NCT03619252 2022-08-31
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 4 Completed
NCT05133310 2022-01-04
Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia
Hospital General de Mexico
Phase 4 Unknown
NCT04187755 2019-12-06
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
Indonesia University
Phase 4 Completed
NCT03793205 2019-01-07
G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients
Peking Union Medical College Hospital
Phase 4 Unknown
NCT01222819 2016-04-06
G-CSF
Rabin Medical Center
Phase 4 Terminated
NCT02463747 2015-06-04
RR
Tel-Aviv Sourasky Medical Center
Phase 4 Unknown
NCT00454272 2009-03-06
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
Sanofi
Phase 4 Completed